阿拉丁(688179) - 阿拉丁接待投资者调研活动记录（2024年11月19日-11月20日）

Group 1: Market Competition - The domestic research reagent market is primarily dominated by foreign brands, but there is a shift towards relative monopoly as domestic brands achieve international standards and partially replace imports [2] Group 2: Overseas Business Development - Aladdin plans to acquire 100% equity of UNA 589 Equity Management GmbH for €28,500 to expand its business in Germany and Europe [3] - The company intends to increase its investment in neoLab Migge GmbH by €888,900 to establish a stable long-term distributor relationship for sales in Germany and Europe [3] - Orders from overseas markets are starting to come in as the company continues to stock products and improve its overseas warehousing [3] Group 3: Financial Performance - In the first three quarters of 2023, the growth rate of the company's expenses was only 4.3%, lower than the growth rate of operating income, ensuring net profit growth [5] - The company maintains a stable gross profit margin, indicating that product prices have not been impacted by price wars [6] Group 4: Investor Relations - The investor meeting held on November 19-20, 2024, did not involve any major information that needs to be disclosed [7]